Longevity Vision Fund - aVenture Asset Manager Research
Location
New York City, NY, US
Founded
2019
Longevity Vision Fund (LVF) is a venture capital firm focused on investing in disruptive healthcare technologies aimed at extending and improving human life. The firm typically participates in Series A, B, and C funding rounds, with investments ranging from early to growth stages. LVF targets innovations in life sciences and healthcare sectors, aiming to make longevity breakthroughs more accessible and affordable.
Notable portfolio companies include 4D Molecular Therapeutics, Biolinq, Eko Health, Exo, Freenome, Insilico Medicine, Juvenescence, Laronde, LyGenesis, Senda Biosciences, and Valo Health. LVF's investment philosophy centers on supporting transformative technologies with the potential to significantly impact human health and longevity. The firm offers unique value-add services such as strategic guidance and access to a network of industry experts to help portfolio companies scale effectively.
Longevity Vision Fund - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
